Notify me when Bios Equity Partners, LP files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| LTRN | Lantern Pharma Inc. | Common Stock, par value $0.0001 per share | 9.98% | $4.15M | 1.08M | CAVU MANAGEMENT, LP | Jun 12, 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|